Optimized use of the FilmArray Meningitis/Encephalitis panel for early discontinuation of antibiotic therapy
Microbiology Spectrum · 02.06.2026 · 14 (6)
DOI: 10.1128/spectrum.00566-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 02.06.2026. Verfasst von Nathan Nicolau-Guillaumet und 11 weiteren Autor:innen. Beteiligte Einrichtung: INSERM, CHU de Reims, Laboratoire de Bactériologie-Virologie-Hygiène hospitalière, P3Cell, U 1250, Université de Reims Champagne-Ardenne, Reims, Fran…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Meningitis, Encephalitis, Molecular Diagnostic Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Suspected meningitis/encephalitis cases require prompt empirical antimicrobial therapy. Syndromic diagnostics like the FilmArray Meningitis/Encephalitis (FAME) panel offer rapid results and are increasingly used despite high costs. This study assessed FAME’s integration in clinical microbiology laboratories’ everyday practice and its impact on early treatment decisions. The FilmArray Meningitis/encephalitis panel Outcome Study (FAMOuS) retrospectively reviewed biological data, treatments before/after FAME, and outcomes from 783 patients across six French hospitals over a 3-year period. FAME results were 80% negative, 7% bacterial, and 13% viral, with no bacterial false negatives. Positive results in samples with
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- INSERM, CHU de Reims, Laboratoire de Bactériologie-Virologie-Hygiène hospitalière, P3Cell, U 1250, Université de Reims Champagne-Ardenne, Reims, France.
- CHU de Reims, Service de Médecine Interne, Maladies Infectieuses et Immunologie Clinique, Université de Reims Champagne-Ardenne, Reims, France.
- Laboratoire de Bactériologie et d'Hygiène Hospitalière, CHU de Poitiers, Poitiers, France.
- Service de Microbiologie Clinique, Hôpitaux Paris Saint-Joseph and Marie-Lannelongue, Paris, France.
- Institut Micalis UMR 1319, Université Paris-Saclay, INRAe, AgroParisTech, Orsay, France.
- Département de Biologie Médicale, Hôpital National d'Instruction des Armées (HNIA) BEGIN, Saint-Mandé, France.
ORCID-Profile: Thomas Guillard
Zitieren
APA
Nicolau-Guillaumet, N., Moutel, M., Plouzeau-Jayle, C., Pean de Ponfilly, G., Courbin, V., Ranc, A. G., Revillet, H., Mourvillier, B., Hentzien, M., Muggeo, A., Guillard, T., & GMC Study Group (2026). Optimized use of the FilmArray Meningitis/Encephalitis panel for early discontinuation of antibiotic therapy. Microbiology Spectrum, 14(6). https://doi.org/10.1128/spectrum.00566-26
Vancouver
Nicolau-Guillaumet N, Moutel M, Plouzeau-Jayle C, Pean de Ponfilly G, Courbin V, Ranc AG, et al. Optimized use of the FilmArray Meningitis/Encephalitis panel for early discontinuation of antibiotic therapy. Microbiology Spectrum. 2026;14(6). doi:10.1128/spectrum.00566-26
BibTeX
@article{NicolauGuillaumet2026,
author = {Nicolau-Guillaumet, Nathan and Moutel, Marin and Plouzeau-Jayle, Chloé and Pean de Ponfilly, Gauthier and Courbin, VIrginie and Ranc, Anne-Gaëlle and Revillet, Hélène and Mourvillier, Bruno and Hentzien, Maxime and Muggeo, Anaëlle and Guillard, Thomas and GMC Study Group, GMC Study Group},
title = {Optimized use of the FilmArray Meningitis/Encephalitis panel for early discontinuation of antibiotic therapy},
journal = {Microbiology Spectrum},
year = {2026},
volume = {14},
number = {6},
doi = {10.1128/spectrum.00566-26}
}
EUVIMED